[HTML][HTML] Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura, TJ Peto… - Malaria journal, 2018 - Springer
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most
common enzymopathy worldwide. Primaquine is the only licensed drug that effectively …

[HTML][HTML] Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone… - Malaria …, 2018 - malariajournal.biomedcentral.com
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy
worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura… - Malaria …, 2018 - search.proquest.com
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

G Henriques, K Phommasone, RT Rupam Tripura… - 2018 - cabidigitallibrary.org
Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most
common enzymopathy worldwide. Primaquine is the only licensed drug that effectively …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

G Henriques, K Phommasone, R Tripura… - Malaria …, 2018 - search.ebscohost.com
Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most
common enzymopathy worldwide. Primaquine is the only licensed drug that effectively …

[PDF][PDF] Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura, TJ Peto… - 2018 - ris.cdu.edu.au
Abstract Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most
common enzymopathy worldwide. Primaquine is the only licensed drug that effectively …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura, TJ Peto… - Malaria Journal, 2018 - go.gale.com
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura… - Malaria …, 2018 - researchers.cdu.edu.au
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

G Henriques, K Phommasone, R Tripura… - Malaria …, 2018 - mahidol.elsevierpure.com
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes …

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.

G Henriques, K Phommasone, R Tripura, TJ Peto… - Malaria …, 2018 - europepmc.org
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes …